SCHEMBL18196917

SCHEMBL18196917

CNCc1cn(S(=O)(=O)c2cccc(OC(F)F)c2)c(-c2ccccc2F)c1OC

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTR6 P50406 5/20 0.36
▸ KDM2B Q8NHM5 1/20 0.36
▸ RORC P51449 5/20 0.36
▸ ELAVL1 Q15717 1/20 0.35
▸ SCN9A Q15858 2/20 0.35
▸ KAT6A Q92794 1/20 0.35
▸ BRD4 O60885 1/20 0.34
▸ USP9X Q93008 1/20 0.34
▸ DRD2 P14416 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MDM2 Q00987 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20530198 0.99 LMNA (0.36) LMNATSHRMAPK1HTR6KDM2B
SCHEMBL18196881 0.92 MAPK1 (0.44) LMNATSHRMAPK1HTR6ELAVL1
SCHEMBL18196918 0.91 SCN9A (0.37) HTR6KDM2BRORCSCN9ABRD4
Hydrochloric Acid SCHEMBL20530213 0.91 MAPK1 (0.43) LMNATSHRMAPK1HTR6ELAVL1
Hydrochloric Acid SCHEMBL20530239 0.91 SCN9A (0.36) HTR6KDM2BRORCSCN9ABRD4
SCHEMBL18196880 0.85 HTR6 (0.43) HTR6KAT6A
Hydrochloric Acid SCHEMBL20530214 0.84 HTR6 (0.42) HTR6KAT6A
SCHEMBL18196930 0.84 ALDH1A1 (0.39) LMNATSHRHTR6RORCALDH1A1
Hydrochloric Acid SCHEMBL20530210 0.83 ALDH1A1 (0.38) LMNATSHRHTR6RORCALDH1A1
SCHEMBL18196927 0.83 HTR6 (0.40) LMNATSHRMAPK1HTR6ELAVL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP claimed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US claimed
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP disclosed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US disclosed
WO-2016175555-A2 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same GIPR, GRPR, HTR3E LMNA 4810/4885TSHR 277/4885MAPK1 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback